Methylenetetrahydrofolate reductase (MTHFR) C677T/A1298C polymorphisms and susceptibility to Parkinson's disease: A meta-analysis

Journal of the Neurological Sciences

Volumn 335, Issue 1-2, 2013, Pages 14-21

  Wu, Yi Le ^a   Ding, Xiu Xiu ^a   Sun, Ye Huan ^a   Yang, Hui Yun ^a   Sun, Liang ^a  

^a ANHUI MEDICAL UNIVERSITY   (China)

Author keywords

Homocysteine; Meta analysis; Methylenetetrahydrofolate reductase; MTHFR; Parkinson's disease; Polymorphism

Indexed keywords

5,10 METHYLENETETRAHYDROFOLATE REDUCTASE (FADH2);

ARTICLE; ASIAN; BIBLIOGRAPHIC DATABASE; CAUCASIAN; COGNITIVE DEFECT; DATA EXTRACTION; DEMENTIA; ETHNICITY; GENETIC ASSOCIATION; GENETIC MODEL; HUMAN; MEDLINE; META ANALYSIS; PARKINSON DISEASE; PRIORITY JOURNAL; SINGLE NUCLEOTIDE POLYMORPHISM;

HOMOCYSTEINE; META-ANALYSIS; METHYLENETETRAHYDROFOLATE REDUCTASE; MTHFR; PARKINSON'S DISEASE; POLYMORPHISM;

DATABASES, BIBLIOGRAPHIC; GENETIC PREDISPOSITION TO DISEASE; HUMANS; METHYLENETETRAHYDROFOLATE REDUCTASE (NADPH2); PARKINSON DISEASE; POLYMORPHISM, GENETIC;

EID: 84888131702     PISSN: 0022510X     EISSN: 18785883     Source Type: Journal    
DOI: 10.1016/j.jns.2013.09.006     Document Type: Review

References (30)

1. S. Przedborski Pathogenesis of nigral cell death in Parkinson's disease Parkinsonism Relat Disord 11 2005 S3 S7
2. S. Searles Nielsen, T.K. Bammler, L.G. Gallagher, F.M. Farin, W. Longstreth Jr., and G.M. Franklin Genotype and age at Parkinson disease diagnosis Int J Mol Epidemiol Genet 4 2013 61 69
3. A. Dumitriu, J.C. Latourelle, T.C. Hadzi, N. Pankratz, D. Garza, and J.P. Miller Gene expression profiles in Parkinson disease prefrontal cortex implicate FOXO1 and genes under its transcriptional regulation PLoS Genet 8 2012 e1002794
4. M.C. Rodriguez-Oroz, P.M. Lage, J. Sanchez-Mut, I. Lamet, J. Pagonabarraga, and J.B. Toledo Homocysteine and cognitive impairment in Parkinson's disease: a biochemical, neuroimaging, and genetic study Mov Disord 24 2009 1437 1444
5. R.Y. Yuan, J.J. Sheu, J.M. Yu, C.J. Hu, I.J. Tseng, and C.S. Ho Methylenetetrahydrofolate reductase polymorphisms and plasma homocysteine in levodopa-treated and non-treated Parkinson's disease patients J Neurol Sci 287 2009 64 68
6. R. Castro, I. Rivera, P. Ravasco, C. Jakobs, H.J. Blom, and M.E. Camilo 5,10-Methylenetetrahydrofolate reductase 677C->T and 1298A->C mutations are genetic determinants of elevated homocysteine QJM 96 2003 297 303
7. S. Seshadri, A. Beiser, J. Selhub, P.F. Jacques, I.H. Rosenberg, and R.B. D'Agostino Plasma homocysteine as a risk factor for dementia and Alzheimer's disease N Engl J Med 346 2002 476 483
8. K. Imamura, T. Takeshima, K. Nakaso, and K. Nakashima Homocysteine is toxic for dopaminergic neurons in primary mesencephalic culture Neuroreport 18 2007 1319 1322
9. C.S. Fong, H.Y. Shyu, J.C. Shieh, Y.P. Fu, T.Y. Chin, and H.W. Wang Association of MTHFR, MTR, and MTRR polymorphisms with Parkinson's disease among ethnic Chinese in Taiwan Clin Chim Acta 412 2011 332 338
10. J.P. Higgins, S.G. Thompson, J.J. Deeks, and D.G. Altman Measuring inconsistency in meta-analyses BMJ 327 2003 557 560
11. R. DerSimonian, and N. Laird Meta-analysis in clinical trials Control Clin Trials 7 1986 177 188
12. N. Mantel, and W. Haenszel Statistical aspects of the analysis of data from retrospective studies of disease J Natl Cancer Inst 22 1959 719 748
13. M. Egger, G. Davey Smith, M. Schneider, and C. Minder Bias in meta-analysis detected by a simple, graphical test BMJ 315 1997 629 634
14. U. Wüllner, H. Kölsch, and M. Linnebank Methylenetetrahydrofolate reductase in Parkinson's disease Ann Neurol 58 2005 972 973
15. D.L. Harmon, D. Ramsbottom, A.S. Whitehead, Y. Ben-Shlomo, and G. Davey-Smith The thermolabile variant of 5,10-methylenetetrahydrofolate reductase is not associated with Parkinson's disease J Neurol Neurosurg Psychiatry 62 1997 671
16. K. Yasui, H. Kowa, K. Nakaso, T. Takeshima, and K. Nakashima Plasma homocysteine and MTHFR C677T genotype in levodopa-treated patients with PD Neurology 55 2000 437 440
17. Y. Momose, M. Murata, K. Kobayashi, M. Tachikawa, Y. Nakabayashi, and I. Kanazawa Association studies of multiple candidate genes for Parkinson's disease using single nucleotide polymorphisms Ann Neurol 51 2002 133 136
18. L.M. de Lau, P.J. Koudstaal, J.B. van Meurs, A.G. Uitterlinden, A. Hofman, and M.M. Breteler Methylenetetrahydrofolate reductase C677T genotype and PD Ann Neurol 57 2005 927 930
19. Z. Todorović, E. Dzoljić, I. Novaković, D. Mirković, R. Stojanović, and Z. Nesić Homocysteine serum levels and MTHFR C677T genotype in patients with Parkinson's disease, with and without levodopa therapy J Neurol Sci 248 2006 56 61
20. D. Religa, K. Czyzewski, M. Styczynska, B. Peplonska, J. Lokk, and M. Chodakowska-Zebrowska Hyperhomocysteinemia and methylenetetrahydrofolate reductase polymorphism in patients with Parkinson's disease Neurosci Lett 404 2006 56 60
21. J.J. Lin, K.C. Yueh, C.S. Liu, J.T. Liu, and S.Z. Lin 5,10-Methylenetetrahydrofolate reductase C677T gene polymorphism can influence age at onset of Parkinson's disease Acta Neurol Taiwan 16 2007 150 157
22. J. Dorszewska, J. Florczak, A. Rozycka, B. Kempisty, J. Jaroszewska-Kolecka, and K. Chojnacka Oxidative DNA damage and level of thiols as related to polymorphisms of MTHFR, MTR, MTHFD1 in Alzheimer's and Parkinson's diseases Acta Neurobiol Exp (Wars) 67 2007 113 129
23. D. Caccamo, G. Gorgone, M. Currò, G. Parisi, W. Di Iorio, and C. Menichetti Effect of MTHFR polymorphisms on hyperhomocysteinemia in levodopa-treated Parkinsonian patients Neuromolecular Med 9 2007 249 254
24. R.M. Camicioli, T.P. Bouchard, and M.J. Somerville Homocysteine is not associated with global motor or cognitive measures in nondemented older Parkinson's disease patients Mov Disord 24 2009 176 182
25. M. Białecka, M. Kurzawski, A. Roszmann, P. Robowski, E.J. Sitek, and K. Honczarenko Association of COMT, MTHFR, and SLC19A1 (RFC-1) polymorphisms with homocysteine blood levels and cognitive impairment in Parkinson's disease Pharmacogenet Genomics 22 2012 716 724
26. G. Gorgone, M. Currò, N. Ferlazzo, G. Parisi, L. Parnetti, and V. Belcastro Coenzyme Q10, hyperhomocysteinemia and MTHFR C677T polymorphism in levodopa-treated Parkinson's disease patients Neuromolecular Med 14 2012 84 90
27. A. Samii, J.G. Nutt, and B.R. Ransom Parkinson's disease Lancet 363 2004 1783 1793
28. C.C. McCulloch, D.M. Kay, S.A. Factor, A. Samii, J.G. Nutt, and D.S. Higgins Exploring gene-environment interactions in Parkinson's disease Hum Genet 123 2008 257 265
29. P. Allain, B.A. Le, E. Cordillet, Q.L. Le, H. Bagheri, and J.L. Montastruc Sulfate and cysteine levels in the plasma of patients with Parkinson's disease Neurotoxicology 16 1995 527 529
30. C.M. Nascimento, F. Stella, C.R. Garlipp, R.F. Santos, S. Gobbi, and L.T. Gobbi Serum homocysteine and physical exercise in patients with Parkinson's disease Psychogeriatrics 11 2011 105 112